Treatment of heroin dependence

German Journal of Psychiatry

Volumn 7, Issue 2, 2004, Pages 1-5

  Ahmadi, Jamshid ^a,b   Farrashbandi, Hassan ^a   Moosavinasab, Masoud ^a   Babaee, Mohammadali ^a   Firoozabadi, Ali ^a   Mohagheghzadeh, Mohammadsadegh ^a   Porter, Joel ^a   Pridmore, Saxby ^a   Dehbozorgi, Gholamreza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Buprenorphine; Heroin dependence; Methadone; Naltrexone; Substance abuse

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; NALTREXONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DRUG EFFICACY; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 25444472385     PISSN: 14331055     EISSN: 14331055     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC
2. Bickel, W. R.., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R. Johnson, R. E. (1988) A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clinical Pharmacology and Experimental Therapeutics, 43, 72-78
3. Bulingham, R. E. S., McQuay, H. J., Porter, E. J. B., Allen, M. C. Moore, R. A. (1982) Sublingual buprenorphine used postoperatively: ten hours plasma drug concentration analysis. British Journal of Clinical Pharmacology, 1, 665-673
4. Drug Control Headquarters (1997) The Anti Narcotics law of the Islamic Republic of Iran (as amended November 1997). Drug Control Headquarters. Tehran. Iran [http://www.dchqiran.org/document/ Law-1997.htm]
5. Drug Control Headquarters, International Relations Office (2001) The National Drug Control Report-2000. Drug Control Headquarters. Tehran, Islamic Republic of Iran
6. Fischer, G., Jagsch, R., Eder, H. Gombas, W., Etzersdorfer, P., Schmidl-Mohl, K., Schatten, C., Weninger, M., Aschauer, H. N. (1999). Comparison of methadone and slow-release morphine maintenance in pregnant addicts. Addiction, 94, 231-239
7. Jasinski, D. R., Fudala, P. J., Johnson, R. E. (1989). Sublingual versus subcutaneous buprenorphine in opiate abusers. Clinical Pharmacology and Therapeutics, 45, 513-519
8. Jasinski, D. R., Pevnick, J. S., Griffith, J. D. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Archives of General Psychiatry, 35, 501-516
9. Johnson, R. E., Jaffe, J. H., Fudala, P. J. (1992). A controlled trial of buprenorphine treatment for opioid dependence. Journal of the American Medical Association, 267, 2750-2755
10. Kolar, A. F., Brown, B. S., Weddington, W. W. ball, J. c. (1990) A treatment crisis: cocaine use by clients in methadone maintenance programs. Journal of substance abuse treatment, 7, 101 - 107
11. Lange, W. R., Fudala, P. J., Dax, E. M., Johnson, R. E. (1990). Safety and side effects of buprenorphine in the clinical management of heroin addiction. Drug and Alcohol Dependence, 26, 19-28
12. Lewis, J. W. (1985). Buprenorphine. Drug and Alcohol Dependence, 14, 363-372
13. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S. Jr., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. A. Jr., Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I, Segal, D. (1998). Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93, 475-486
14. Ling, W., Rawson, R. A., Compton, M. A. (1994). Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. Journal of Psychoactive Drugs, 26, 119-128
15. Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., Gilbert, P. E. (1976). The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics, 197, 517-532
16. Moore, M. (2001) Iran: once hidden, drug addiction is changing Iran. Washington Post (DC). Wednesday 18 July (p. 26). [http://.maoinc.org/drugnews/v0l/nl344/a06.htm12072]
17. Newman, R. G. (1987) Methadone treatment. New England Journal of Medicine, 317, 447-450
18. Patricio, L. D., Miguel, N. (1994). Role of LAAM, methadone and naltrexone in the care of opiate dependence: experience in Portugal. Annals de Medecine Interne (Paris), 145, 28-30
19. Plomp, H. N., Van Der Hek, H. Ader, H. J. (1996). The Amsterdam methadone dispensing circuit: genesis and effectiveness of a public health model for local drug politics. Addiction, 91, 711-712
20. Razzaghi, E. Rahimi, A. Hosseini, M. Chatterjee A. (1999) Rapid Situation Assessment (RSA) of Drug Abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, I.R. of Iran and United Nations International Drug Control Program
21. Schottenfeld, R. S., Kleber, H. D. (1995) Methadone maintenance, in: Kaplan, H. I. Sadock, B. J. (Eds) Comprehensive Textbook of psychiatry, pp. 2031-2038 (Baltimore Williams Wilkins)
22. Strain, E. C., Stitzer, M. L., Liebson, I. A., Bigelow, G. E. (1994). Comparison of buprenorphine and methadone in the treatment of opioid dependence. American Journal of Psychiatry, 151, 1025-1030